This is a Validated Antibody Database (VAD) review about mouse Aldh1a1, based on 21 published articles (read how Labome selects the articles), using Aldh1a1 antibody in all methods. It is aimed to help Labome visitors find the most suited Aldh1a1 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
Aldh1a1 synonym: ALDH-E1; ALHDII; Ahd-2; Ahd2; Aldh1; Aldh1a2; E1; Raldh1

Abcam
domestic rabbit monoclonal (EP1933Y)
  • western blot; human; 1:3000; fig 1d
Abcam Aldh1a1 antibody (Abcam, ab52492) was used in western blot on human samples at 1:3000 (fig 1d). Mol Med Rep (2019) ncbi
domestic rabbit monoclonal (EP1933Y)
  • immunohistochemistry - paraffin section; human; 1:200; loading ...; fig 2g
Abcam Aldh1a1 antibody (Abcam, EP1933Y) was used in immunohistochemistry - paraffin section on human samples at 1:200 (fig 2g). Pathol Oncol Res (2018) ncbi
domestic rabbit monoclonal (EP1933Y)
  • immunohistochemistry; mouse; 1:50; loading ...; fig 4
Abcam Aldh1a1 antibody (Abcam, ab52492) was used in immunohistochemistry on mouse samples at 1:50 (fig 4). Dev Biol (2017) ncbi
domestic rabbit monoclonal (EP1933Y)
  • immunohistochemistry; mouse; fig s1a
In order to examine IFN responses by cerebellar astrocytes during viral infection, Abcam Aldh1a1 antibody (Abcam, ab52492) was used in immunohistochemistry on mouse samples (fig s1a). J Clin Invest (2017) ncbi
domestic rabbit monoclonal (EP1933Y)
  • immunohistochemistry - paraffin section; human; 1:100; loading ...; tbl 3
Abcam Aldh1a1 antibody (Abcam, ab52492) was used in immunohistochemistry - paraffin section on human samples at 1:100 (tbl 3). Oncotarget (2016) ncbi
domestic rabbit monoclonal (EP1933Y)
  • immunocytochemistry; human; 1:100; fig s2
Abcam Aldh1a1 antibody (Abcam, ab52492) was used in immunocytochemistry on human samples at 1:100 (fig s2). Sci Rep (2016) ncbi
domestic rabbit monoclonal (EP1933Y)
  • immunohistochemistry - paraffin section; human; 1:500; tbl 2
Abcam Aldh1a1 antibody (Abcam, ab52492) was used in immunohistochemistry - paraffin section on human samples at 1:500 (tbl 2). PLoS ONE (2016) ncbi
domestic rabbit monoclonal (EP1933Y)
  • immunocytochemistry; human; fig 4
Abcam Aldh1a1 antibody (Abcam, ab52492) was used in immunocytochemistry on human samples (fig 4). Oncotarget (2016) ncbi
domestic rabbit monoclonal (EP1933Y)
  • immunohistochemistry; human; 1:200; fig 8
Abcam Aldh1a1 antibody (Abcam, ab52492) was used in immunohistochemistry on human samples at 1:200 (fig 8). Nat Commun (2015) ncbi
domestic rabbit monoclonal (EP1933Y)
  • immunohistochemistry; mouse; 1:100; fig 6
Abcam Aldh1a1 antibody (Abcam, ab52492) was used in immunohistochemistry on mouse samples at 1:100 (fig 6). Aging (Albany NY) (2015) ncbi
domestic rabbit monoclonal (EP1933Y)
  • immunocytochemistry; human; 1:1000; fig 6
Abcam Aldh1a1 antibody (Abcam, ab52492) was used in immunocytochemistry on human samples at 1:1000 (fig 6). Sci Rep (2015) ncbi
domestic rabbit monoclonal (EP1933Y)
  • western blot; rat; fig 1
Abcam Aldh1a1 antibody (Abcam, ab52492) was used in western blot on rat samples (fig 1). EMBO Mol Med (2015) ncbi
domestic rabbit monoclonal (EP1933Y)
  • immunohistochemistry; human; 1:100
In order to evaluate the presence of cancer stem cells and EMT markers as prognostic markers for breast metaplastic carcinoma, Abcam Aldh1a1 antibody (Abcam, Ab52492) was used in immunohistochemistry on human samples at 1:100. Breast Cancer Res Treat (2015) ncbi
domestic rabbit monoclonal (EP1933Y)
  • immunohistochemistry - paraffin section; human; 1:100
In order to investigate the effect of neoadjuvant chemoradiotherapy on pancreatic adenocarcinoma cancer stem cell markers, Abcam Aldh1a1 antibody (Abcam, ab52492) was used in immunohistochemistry - paraffin section on human samples at 1:100. BMC Cancer (2014) ncbi
domestic rabbit monoclonal (EP1933Y)
  • immunohistochemistry - paraffin section; human; 1:250
In order to study the clinical significance of aldehyde dehydrogenase 1 expression in the invasive front of nasopharyngeal carcinoma, Abcam Aldh1a1 antibody (Abcam, EP1933Y) was used in immunohistochemistry - paraffin section on human samples at 1:250. Virchows Arch (2014) ncbi
domestic rabbit monoclonal (EP1933Y)
  • immunohistochemistry - paraffin section; human
Abcam Aldh1a1 antibody (Abcam, ab52492) was used in immunohistochemistry - paraffin section on human samples . PLoS Genet (2012) ncbi
Santa Cruz Biotechnology
mouse monoclonal (H-8)
  • western blot; mouse; 1:500; loading ...; fig 3d
Santa Cruz Biotechnology Aldh1a1 antibody (Santa Cruz, sc-166362) was used in western blot on mouse samples at 1:500 (fig 3d). EMBO Mol Med (2021) ncbi
mouse monoclonal (H-8)
  • western blot; mouse; loading ...; fig 1c
Santa Cruz Biotechnology Aldh1a1 antibody (Santacruz, SC-166362) was used in western blot on mouse samples (fig 1c). Cell Death Dis (2021) ncbi
mouse monoclonal (H-8)
  • flow cytometry; human
Santa Cruz Biotechnology Aldh1a1 antibody (Santa Cruz Biotechnology, sc-166362) was used in flow cytometry on human samples . PLoS ONE (2014) ncbi
Cell Signaling Technology
domestic rabbit monoclonal (D4R9V)
  • western blot; human; fig 5
In order to characterize androgen receptor-targeted and vitamin D therapy for triple-negative breast cancer, Cell Signaling Technology Aldh1a1 antibody (Cell Signalling, 12035) was used in western blot on human samples (fig 5). Breast Cancer Res Treat (2016) ncbi
domestic rabbit monoclonal (D4R9V)
  • western blot; human; fig 2a
Cell Signaling Technology Aldh1a1 antibody (Cell Signaling, 12035) was used in western blot on human samples (fig 2a). Oncotarget (2014) ncbi
Articles Reviewed
  1. Herranz C, Mateo F, Baiges A, Ruiz de Garibay G, Junza A, Johnson S, et al. Histamine signaling and metabolism identify potential biomarkers and therapies for lymphangioleiomyomatosis. EMBO Mol Med. 2021;13:e13929 pubmed publisher
  2. Russo A, Colina J, Moy J, Baligod S, Czarnecki A, Varughese P, et al. Silencing PTEN in the fallopian tube promotes enrichment of cancer stem cell-like function through loss of PAX2. Cell Death Dis. 2021;12:375 pubmed publisher
  3. Zhang C, Wang Y. Metformin attenuates cells stemness and epithelial‑mesenchymal transition in colorectal cancer cells by inhibiting the Wnt3a/β‑catenin pathway. Mol Med Rep. 2019;19:1203-1209 pubmed publisher
  4. Ju X, Sun K, Liu R, Li S, Abulajiang G, Zou H, et al. Exploring the Histogenesis and Diagnostic Strategy Using Immunoassay and RT-PCR in Alveolar Soft Part Sarcoma. Pathol Oncol Res. 2018;24:593-600 pubmed publisher
  5. Minkina A, Lindeman R, Gearhart M, Chassot A, Chaboissier M, Ghyselinck N, et al. Retinoic acid signaling is dispensable for somatic development and function in the mammalian ovary. Dev Biol. 2017;424:208-220 pubmed publisher
  6. Daniels B, Jujjavarapu H, Durrant D, Williams J, Green R, White J, et al. Regional astrocyte IFN signaling restricts pathogenesis during neurotropic viral infection. J Clin Invest. 2017;127:843-856 pubmed publisher
  7. Yu J, Li X, Zhong C, Li D, Zhai X, Hu W, et al. High-throughput proteomics integrated with gene microarray for discovery of colorectal cancer potential biomarkers. Oncotarget. 2016;7:75279-75292 pubmed publisher
  8. Hanssen A, Wagner J, Gorges T, Taenzer A, Uzunoglu F, Driemel C, et al. Characterization of different CTC subpopulations in non-small cell lung cancer. Sci Rep. 2016;6:28010 pubmed publisher
  9. Thakkar A, Wang B, Picon Ruiz M, Buchwald P, Ince T. Vitamin D and androgen receptor-targeted therapy for triple-negative breast cancer. Breast Cancer Res Treat. 2016;157:77-90 pubmed publisher
  10. Sato K, Suda K, Shimizu S, Sakai K, Mizuuchi H, Tomizawa K, et al. Clinical, Pathological, and Molecular Features of Lung Adenocarcinomas with AXL Expression. PLoS ONE. 2016;11:e0154186 pubmed publisher
  11. Kim J, Lee H, Park K, Choi Y, Nam J, Hong I. CWP232228 targets liver cancer stem cells through Wnt/β-catenin signaling: a novel therapeutic approach for liver cancer treatment. Oncotarget. 2016;7:20395-409 pubmed publisher
  12. Kim T, Yang S, Hwang D, Song J, Kim M, Kyum Kim S, et al. A basal-like breast cancer-specific role for SRF-IL6 in YAP-induced cancer stemness. Nat Commun. 2015;6:10186 pubmed publisher
  13. Papaconstantinou J, Wang C, Zhang M, Yang S, DeFord J, Bulavin D, et al. Attenuation of p38α MAPK stress response signaling delays the in vivo aging of skeletal muscle myofibers and progenitor cells. Aging (Albany NY). 2015;7:718-33 pubmed
  14. Foster J, Gouveia R, Connon C. Low-glucose enhances keratocyte-characteristic phenotype from corneal stromal cells in serum-free conditions. Sci Rep. 2015;5:10839 pubmed publisher
  15. Lee H, Jeong H, Park S, Yoo W, Choi S, Choi K, et al. Fusion protein of retinol-binding protein and albumin domain III reduces liver fibrosis. EMBO Mol Med. 2015;7:819-30 pubmed publisher
  16. Oon M, Thike A, Tan S, Tan P. Cancer stem cell and epithelial-mesenchymal transition markers predict worse outcome in metaplastic carcinoma of the breast. Breast Cancer Res Treat. 2015;150:31-41 pubmed publisher
  17. Chandrasekaran S, Marshall J, Messing J, Hsu J, King M. TRAIL-mediated apoptosis in breast cancer cells cultured as 3D spheroids. PLoS ONE. 2014;9:e111487 pubmed publisher
  18. Mizukami T, Kamachi H, Mitsuhashi T, Tsuruga Y, Hatanaka Y, Kamiyama T, et al. Immunohistochemical analysis of cancer stem cell markers in pancreatic adenocarcinoma patients after neoadjuvant chemoradiotherapy. BMC Cancer. 2014;14:687 pubmed publisher
  19. Yang Y, Zhou W, Xia J, Gu Z, Wendlandt E, Zhan X, et al. NEK2 mediates ALDH1A1-dependent drug resistance in multiple myeloma. Oncotarget. 2014;5:11986-97 pubmed
  20. Luo W, Yao K. Cancer stem cell characteristics, ALDH1 expression in the invasive front of nasopharyngeal carcinoma. Virchows Arch. 2014;464:35-43 pubmed publisher
  21. Maddox J, Shakya A, South S, Shelton D, Andersen J, Chidester S, et al. Transcription factor Oct1 is a somatic and cancer stem cell determinant. PLoS Genet. 2012;8:e1003048 pubmed publisher